PUBLIKATIONSLISTE - Ludwig Boltzmann Institut für COPD
1.) Publikationen (Originalarbeiten)
1. Valipour A, Koller H, Kreuzer A, Kössler W, Csokay A, Burghuber OC. A case of primary tularemic pneumonia presenting with necrotizing mediastinal and hilar lymph nodes WiKliWo 2003, 115/196-199, IF: 0.9 2. Petkov V, Mosgöller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, Block LH. Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest. 2003, 111:1339-46, IF 16.9 3. Stiebellehner L, Petkov V, Vonbank K, Funk GC, Schenk P, Ziesche R, Block LH. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest. 2003, 123:1293-5, IF 4.1 4. Bauer E, Funk GC, Gendo A, Kramer L, Zauner C, Sterz F, Schneider B, Madl C. Electrophysiological assessment of the afferent sensory pathway in cardiac arrest survivors. Eur J Clin Invest. 2003, 33:283-7, IF 2.7 5. Mc Gown AD, Alwell C, Makker HK, Al-Rawi P, Valipour A, Spiro SG. Measurement of changes in cytochrome oxidase redox state during obstructive sleep apnoea using near infra-red spectroscopy. Sleep 2003, 26:710-716 6. Valipour A, Cozzarini W, Burghuber OC. Non-invasive pressure support ventilation in patients with respiratory failure due to severe acute cardiogenic pulmonary edema Respiration 2004, 71 (2): 144 – 151, IF 1.9 7. Kössler W, Valipour A, Feldner-Busztin M, Wanke T, Zifko U, Zwick H, Burghuber OC. Spontaneous bilateral diaphragmatic paralysis: a rare cause of respiratory failure. WiKliWo 2004, 116/565-567, IF 0.9 8. Valipour A, Litschauer B, Mittermayer F, Rauscher H, Burghuber OC, Wolzt M. Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. Respir Med 2004, 98(12): 1180 – 1186, IF 2.2 9. Funk GC, Doberer D, Heinze G, Madl C, Holzinger U, Schneeweiss B. Changes of serum chloride and metabolic acid-base state in critical illness. Anaesthesia. 2004, 59:1111-5, IF 2,3
10. Alt E, Amann-Vesti BR, Madl C, Funk GC, Koppensteiner R. Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score. Clin Hemorheol Microcirc. 2004, 30:107-15, IF 1 11. Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy guided topical hemostatic tamponade therapy for the management of life threatening hemoptysis. Chest 2005, 127: 2113-2118, IF 4.1 12. Valipour A, Schneider F, Koessler W, Saliba S, Burghuber OC. Heart rate variability and spontaneous baroreflex sequences in supine healthy volunteers subjected to nasal positive airway pressure. J Appl Physiol 2005, 99(6): 2137-2143, IF 3.6 13. Valipour A, Koller H, Setinek U, Burghuber OC. Pleural empyema associated with Gemella morbillorum: report of a case and review of the literature. Scand J Infect Dis 2005, 37(5): 378-381, IF 1.1 14. Prebio M, Katz-Papatheophilou E, Heindl W, Gelbmann H, Burghuber OC. Verminderung von Hautdefekten bei Bauchlagerung bei beatmeten Intensivpatienten durch das Prone-Head-Support-System: eine Pilotstudie. WiKliWo 2005, 117/3: 98-105, IF 0.9 15. Kramer L, Hofer H, Bauer E, Funk GC, Formann E, Steindl-Munda P, Ferenci P. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. AIDS. 2005, 19 Suppl 3: 85-92, IF 5.8 16. Funk GC, Doberer D, Osterreicher C, Peck-Radosavljevic M, Schmid M, Schneeweiss B. Equilibrium of acidifying and alkalinizing metabolic acid-base disorders in cirrhosis. Liver Int. 2005, 25:505-12, IF 2.6 17. Hochmair M, Valipour A, Oschatz E, Hollaus P, Huber M, Burghuber OC. From a sore throat to the intensive care unit: the Lemierre syndrome. WiKliWo 2006, 118/243-246, IF 0.9 18. Fuhrmann V, Madl C, Mueller C, Holzinger U, Kitzberger R, Funk GC, Schenk P. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006, 131:69-75, IF 11.7 19. Funk GC, Doberer D, Fuhrmann V, Holzinger U, Kitzberger R, Kneidinger N, Lindner G, Schneeweiss B. The acidifying effect of lactate is neutralized by the alkalinizing effect of hypoalbuminemia in non-paracetamol-induced acute liver failure. J Hepatol. 2006, 45:387-92, IF 6.6
20. Valipour A, Lothaller H, Rauscher H, Zwick H, Burghuber OC, Lavie P. Gender related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the Sleep Disorders Questionnaire. Sleep 2007, 30: 306-313, IF 5.0 21. Funk GC, Doberer D, Kneidinger N, Lindner G, Holzinger U, Schneeweiss B. Acid-base disturbances in critically ill patients with cirrhosis. Liver Int. 2007, 27:901-9, IF 2.6 22. Kneidinger N, Lindner G, Fuhrmann V, Doberer D, Dunkler D, Schneeweiss B, Funk GC. Acute phase proteins do not account for unmeasured anions in critical illness. Eur J Clin Invest. 2007, 37:820-5, IF 2.7
23. Eisenburger P, Funk GC, Burda G, Sterz FR, Laggner AN, Herkner H. Gas concentrations in expired air during basic life support using different ratios of compression to ventilation. Resuscitation 2007, 73:115-22, IF 2.5 24. Holzinger U, Kitzberger R, Fuhrmann V, Funk GC, Madl C, Ratheiser K. Correlation of calculated indices of insulin resistance (QUICKI and HOMA) with the euglycaemic hyperinsulinaemic clamp technique for evaluating insulin resistance in critically ill patients. Eur J Anaesthesiol. 2007, 24:966-70, IF 1.4 25. Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, Kramer L, Druml W. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007, 50:952-7, IF 4
26. Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clin Sci 2008, 115: 225-232, IF 3.2 27. Funk GC, Lang I, Schenk P, Imkova I, Valipour A, Burghuber OC. Left ventricular diastolic dysfunction in patients with COPD in presence and absence of elevated pulmonary arterial pressure. Chest. 2008 June, 133(6):1354-9, IF 4.1 28. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC. Determinants of Systemic Vascular Function in Patients with Stable COPD. Am J Respir Crit Care Med. 2008 Oct 3, IF 9.09 29. Vonbank K, Funk GC, Marzluf B, Burian B, Ziesche R, Stiebellehner L, Petkov V, Haber P. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. WiKliWo 2008, 120:749-55, IF 0.9
30. Pitta F, Breyer MK, Hernandes NA, Teixeira D, Sant’Anna TJP, Fontana AD, Probst VS, Brunetto AF, Spruit MA, Wouters EFM, Burghuber OC, Hartl S. Physical activities in daily life in patients with COPD from Central-Europe and South- America: a comparative study. Respir Med. 2009 Mar, 103(3):421-6 31. Kohansal R, Soriano JBS, Agusti A. Investigating the natural history of lung function: facts, pitfalls and opportunities. Chest in Press 2009 32. Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study. Respir Res. 2009 Jan 9, 10(1):1, IF 3.8 33. Kaufmann M, Hartl S, Geyer K, Breyer MK, Burghuber OC. Measuring FEV6 for Detecting Early Airway Obstruction in the Primary Care Setting: Quality and Utility of the New PiKo-6-Device. Respiration 2009, 78:161-167 (DOI: 10.1159/000197466) 34. Zwick R, Burghuber OC, Dovjak N, Hartl S, Kössler W, Lichtenschopf A, Müller R, Zwick H. Der Effekt von einem Jahr ambulanter pneumologischer Rehabilitation auf Patienten mit COPD. WiKliWo 2009, 121/189-195 35. Breyer MK, Spruit MA, Celis AP, Rutten EP, Janssen PP, Wouters EF; CIRO Network: Highly elevated C-reactive protein levels in obese patients with COPD; a fat chance? Clin Nutr. 2009 Dec, 28(6):642-7, IF 3,203 36. Oschatz E, Prosch H, Kohansal R, Valipour A, Mostbeck GH. COPD and Osteoporosis: detection and grading of vertebral fractures on lateral chest radiography. J Thorac Imaging 2009, 24:212-215, IF 1.64 37. Cekici L, Valipour A, Kohansal R, Burghuber O. Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. Br J Clin Pharmacol 2009, 67, 394-402, IF 3.1 38. Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med 2009, 35(2), 232-9, IF 5.1 39. Funk GC, Doberer D, Sterz F, Richling N, Kneidinger N, Lindner G, Schneeweiss B, Eisenburger P. The strong ion gap and outcome after cardiac arrest in patients treated with therapeutic hypothermia: a retrospective study. Intensive Care Med. 2009, 35, 232-9, IF 5.1
40. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009 Jul 1, 180(1), 3-10 41. Walch A, Meshkat M, Reinisch W. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines. Journal of Crohn’s and Colitis, 2010.01.001, IF 0,812 42. Funk GC, Anders S, Breyer MK, Burghuber OC, Edelmann G, Heindl W, Hinterholzer G, Kohansal R, Schuster R, Schwarzmaier-D'Assie A, Valentin A, Hartl S. Eur Respir J 2010, 35, 88-94, IF 5.5
2.) Publikationen (Abstracts)
1. Valipour A, Pils H, Schmidt I, Kössler W, Burghuber OC. Effects of continuous mask positive airway pressure ventilation (CPAP) on cardiopulmonary haemodynamics and baroreflex sensitivity. Clin Auton Res 2003, 13 (1), S 66 2. Valipour A, Litschauer B, Burghuber OC, Rauscher H, Wolzt M, Koller-Strametz J. Plasma vascular endothelial growth factor in patients with episodic versus chronic hypoxia. Am J Respir Crit Care Med 2003, 167; 7 3. Kössler W, Valipour A, Zwick H. Health benefits of smoking cessation in an unselected Austrian population group. Eur Respir J 2003, 22: Suppl 45, 389s 4. Kössler W, Valipour A, Zwick H. Gesundheitsförderung durch Raucherentwöhnung. WiKliWo 2003, 115/10, A1-A13 5. Valipour A, Schneider F, Koessler W, Schmidt I, Burghuber OC. Effects of nasal CPAP on sympathetic activity in normal subjects. Am J Respir Crit Care Med 2004, A 1078, B 43 6. Valipour A, Schneider D, Koessler W, Kiss D, Burghuber OC. Hemodynamic consequences of nasal continuous positive airway pressure (n-CPAP) in normal subjects. Am J Respir Crit Care Med 2004, A 895, B 43
7. Valipour A, Kreuzer A, Koller H, Koessler W, D Kiss, Burghuber OC. Bronchoscopy guided topical hemostatic therapy for the management of life threatening hemoptysis. Eur Respir J 2004, Vol 24, Suppl 48, 699s 8. Kössler W, Valipour A, Burghuber OC, Zwick H. Smoking cessation in unselected outpatients in Austria. Eur Respir J 2004, Vol 24, Suppl 48, 607s 9. Valipour A, Schreder M, Wolzt M, Kapiotis S, Burghuber OC. Serum levels of vascular endothelial growth factor are elevated in patients with acute exacerbated COPD. Eur Respir J 2005, Vol 26, Suppl 49, 350s 10. Hochmair M, Valipour A, Kohansal R, Schmidt I, Geyer K, Burghuber OC. Funktionelle Auswirkungen einer intrahospitalen Rehabilitation bei Patienten mit heterogenem Lungenemphysem. WiKliWo 2005, 117/18, A 32 11. Valipour A, Kohansal R, Burghuber OC. Chemoreceptor vermittelte Antwort des autonomen kardiovaskulären Nervensystems. WiKliWo 2005, 117/18, A 38 12. Zwick RH, Mutzbacher P, Dovlak N, Heinzle C, Burghuber OC. Exercise in addition to nicotine replacement improves success rates in smoking cessation. Chest 2006, 130:145s 13. Valipour A, Lavie P, Lothaller H, Rauscher H, Zwick H, Burghuber OC. Gender-related differences in presenting symptoms of patients with obstructive sleep apnea. Eur Respir J 2006, 648s, P 3772 14. Kohansal R, Valipour A, Burghuber OC. Short term effects of acute laboratory induced hypoxemia on heart rate- and blood pressure variability in healthy subjects. Eur Respir J 2006, 631s, P 3689 15. Eickhoff P, Kiss D, Kohansal R, Valipour A, Geyer K, Burghuber OC. Endothelial dysfunction in stable COPD – a link between systemic inflammation and cardiovascular morbidity? Eur Respir J 2006, 116s, 756 16. Kohansal R, Valipour A, Burghuber OC. Short term effects of acute laboratory induced hypoxemia on heart rate-and blood pressure variability in healthy subjects. Annual Congress of the European Respiratory Society Sept. 2-6, 2006, Munich,Germany, AP 3689
17. Schweiger K, Meshkat M, Novacek G. Open label study of sequential treatment with Metronidazole and E. Coli Nissle 1917 for severe, postop., endoscopic recurrence of Crohn’s disease. Gastroenterology 4/2006, 130, A 657-A 657, Suppl. 2 18. Meshkat M, Ruis M, Valipour A, Burghuber OC. Anatomic abnormalities of the upper airways in patients with sleep disordered breathing. WiKliWo 2007, 119/17-18, A 20 19. Firlinger I, Setinek U, Koller H, Prosch H, Katz-Papatheophilou E, Burghuber OC, Valipour A. Localized Tracheobronchial Amyloidosis treated by bronchoscopic resection: A case report. Jahreskongress der Österreichischen Gesellschaft für Pneumologie; Oct 6 – 8, 2007; Salzburg, Austria. Wi Kli Wo 2007, 119/17–18: A 17 20. Cekici L, Weinhofer B, Burghuber OC, Valipour A. Inhaler technique and peak inspiratory flow rates in patients with acute exacerbated COPD Eur Respir J 2007, Suppl 51, 557s, P 3321 21. Eickhoff P, Kiss D, Schreder M, Kohansal R, Valipour A, Geyer G, Burghuber OC. Increased Intima-Media Thickness in stable COPD – Is Systemic Inflammation the Cause? Eur Respir J 2007, Suppl 51, 224s, E 1372 22. Cekici L, Valipour A, Kohansal R, Burghuber OC. Effects of inhaled salbutamol and ipratropium bromide on cardiovascular autonomic regulation. AJRCCM 2007, Suppl, 444s, PA 937 23. Eickhoff P, Kiss D, Schreder M, Kohansal R, Valipour A, Geyer K, Burghuber OC. Systemic Inflammation and Endothelial Dysfunction in COPD. Am J Respir Crit Care Med 2007; 175, A 516 24. Breyer MK, Hartl S, Kirchheiner K, Schmidt I, Burghuber OC. Improvement of cognitive dysfunction after acute on chronic respiratory failure in patients with COPD. WiKliWo 2007, 119/17-18 25. Kohansal R, Setinek U, Lintner F, Burghuber OC, Valipour A. The use of Real-Time PCR in sputum analysis of patients with acute exacerbated COPD: a pilot-study. WiKliWo 2007, 119/17-18 26. Breyer MK, Hartl S, Kirchheiner K, Schmidt I, Burghuber OC. Improvement of cognitive dysfunction after acute on chronic respiratory failure in patients with COPD. ABRCCM 2007, Suppl 448, PA 738
27. Breyer MK, Spruit MA, Melick van P, Weling-Scheepers C, Rutten EP, Janssen PP, Wouters EFM. Body fat mass in patients with COPD after stratification for body fat mass index and fat free mass index. Eur Respir J 2007, 453s, P 2677 28. Breyer MK, Spruit MA, Rutten EP, Weling-Scheepers C, Melick van P, Janssen PP, Wouters EFM. Prevalence of an energy-restricted diet in COPD patients with increased body mass index and/or body fat mass. Eur Respir J 2007, 94s, P 688 29. Celis MP, Breyer MK, Spruit MA, Rutten EP, Janssen PP, Wouters EFM. Body composition in COPD patients with self-reported cardiovascular co morbidity. Eur Respir J 2007, 452s, P 2676 30. Funk, GC; Zwick, R; Schirnhofer, L, et al. Unloading the ventilatory pump after extubation - are invasive and non-invasive ventilation equal? Jahreskongress der Österreichischen Gesellschaft für Pneumologie; Oct. 6-8, 2007; Salzburg, Austria. WiKliWo 2007, 119/A 17-18 31. Funk, GC; Zwick, R; Schirnhofer, L, et al. Unloading the ventilatory pump after extubation - are invasive and non-invasive ventilation equal? Jahreskongress der Österreichischen Gesellschaft für Pneumologie; Oct. 6-8, 2007, Salzburg, Austria. WiKliWo 2007, 119/A 17-18 32. Breyer MK, Rutten EP, Spruit MA, Hop WC, Wouters EFM. Is CRP the sentinel biomarker of systemic inflammation in COPD? Am J Respir Crit Care Med 2008, 267s, A 647 33. Breyer MK, Spruit MA, Rutten EP, Wouters EFM. Prevalence of the metabolic syndrome in patients with COPD. Am J Respir Crit Care Med 2008, 488s, A1289 34. Breyer MK, Kohansal R, Burghuber OC, Hartl S. Nordic Walking in rehabilitation of COPD. Am J Respir Crit Care Med 2008, 933s, A 134 35. Rutten E, Breyer MK, Spruit M, van Melick P, Hofstra T, Schols A, Wouters E. Fat Mass Distribution in patients with chronic obstructive pulmonary disease (COPD). Espen 2008, P 349 36. Rutten E, Spruit M, Breyer MK, Seerden-Zeijen M, Suntjens-van Teul A, Schols A, Wouters E. Systemic inflammation in COPD is weakly related to fat mass distribution. Espen 2008, P 348
37. Breyer MK, Kohansal R, Burghuber OC, Hartl S. The effects of nordic walking on exercise capacity and physical activity in daily life (AoDL) in COPD. Eur Respir J 2008, 292s, 1754 38. Breyer MK, Kohansal R, Burghuber OC, Hartl S. The natural progression of daily physical activities (AoDL) in COPD. WiKliWo 2008, 120/13-14 39. Breyer MK, Kohansal R, Burghuber OC, Hartl S. The natural progression of daily physical activities (AoDL) in COPD. Eur Respir J 2008, 575s, P 3328 40. Breyer MK, Spruit MA, Rutten EP, Celis MP, Wouters EFM. Metabolic syndrome in COPD patients entering pulmonary rehabilitation. Eur Respir J 2008, 222s, 1326 41. Valipour A, Kapfhammer G, Pokorny R, Pohl W, Vetter N, Burghuber OC. Expiratory pressure-relief reduces the need for heated humidification in association with continuous positive airway pressure therapy for obstructive sleep apnea. Eur Respir J 2008, Suppl; 41s, 380 42. Cekici L, Valipour A, Eickhoff P, Geyer K, Burghuber OC. A prospective study on vascular reactivity of the brachial artery in patients with stable COPD. Eur Respir J 2008, Suppl, 201s, P 1173 43. Ruis M, Mikulic I, Tichelmann F, Burghuber OC, Valipour A Gender-related differences in compliance with continuous positive airway pressure for obstructive sleep apnea. Eur Respir J 2008, 136s, P 859 44. Ruis M, Mikulic I, Tichelmann F, Burghuber OC, Valipour A. Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Eur Respir J 2008, 130s, P 8 45. Funk, GF; Lang, I; Schenk, P, et al. . Jahreskongress der Österreichischen Gesellschaft für Pneumologie; Sept. 18-20, 2008; Vienna, Austria. WiKliWo 2008, 120/13-14, A 18 46. Funk, GC; Breyer, MK; Burghuber, OC, et al. Nocturnal non-invasive positive pressure ventilation (NIPPV) in stable hypercapnic COPD patients - a randomized controlled trial. Jahreskongress der Österreichischen Gesellschaft für Pneumologie; Sept. 18-20, 2008; Vienna, Austria. WiKliWo 2008, 120/13-14, A 19
47. Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for prediction of anxiety and depression in patients with COPD. Jahreskongress der Österreichischen Gesellschaft für Pneumologie, Sept. 18-20, 2008, Vienna, Austria. WiKliWo 2008, 120/13-14, A 18 48. Funk, GC; Breyer, MK; Burghuber, OC, et al. Nocturnal non-invasive positive pressure ventilation (NIPPV) in stable hypercapnic COPD patients - a randomized controlled trial. Annual Congress of the European Respiratory Society; Oct. 4-8, 2008, Berlin, Germany; A 359 49. Hochmair M, Katz-Papatheophilou E, Koller H, Burghuber OC. Akute idiopathische eosinophile Pneumonie. Jahreskongress der Österreichischen Gesellschaft für Pneumologie; 18. – 21. Sept. 2008, Wien. WiKliWo 2008, 120/13–14, A 30 50. Breyer MK, Kohansal R, Burghuber OC, Hartl S. The effects of Nordic walking on exercise capacity and physical activity in daily life (AoDL) in COPD. WiKliWo 2009, 120/13-14 51. Funk GC, Anders S, Breyer MK, Burghuber OC, Edelmann G, Heindl W, Hinterholzer G, Kohansal R, Schuster R, Schwarzmaier-D’Assie A, Valentin A, Hartl S. Incidence and outcome of weaning from mechanical ventilation according to the new consensus categories. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie; 11. - 13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 46 52. Hochmair MJ, Schalleschak J, Kaynak E, Funk GC, Valipour A, Breyer MK, Kohansal R, Prosch H, Kaufmann M, Mashaal S, Burghuber OC. A two hour sedimentation of pleural effusion improves the diagnostic yield in patients with suspected malignancy. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie; 11.-13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 47 53. Rowhani M, Rumetshofer R. MDR-TB an der 1. Internen Lungenabteilung Otto Wagner Spital Wien 2006-2008. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie, 11.-13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 52 54. Ruis M, Burghuber OC, Valipour A. Sleep disordered breathing and cardiac performance indices in patients with stable chronic heart failure. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie, 11.-13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 53
55. Ruis M, Rauscher H, Burghuber OC, Valipour A. Difficulty in initiating and maintaining sleep in patients with stable mild to moderate chronic obstructive pulmonary disease. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie, 11.-13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 53 56. Urban M, Cekici L, Funk GC, Valipour A, Burghuber OC. Endothelia dysfunction and systemic inflammation in stable and exacerbated patients with COPD. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie, 11.-13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 56 57. Zwick RH, Nemeth J, Winkler HM, Rumetshofer R, Burghuber OC, Graninger W, Winkler S. Limitations of immune-based diagnostics in patients suspected for pulmonary tuberculosis. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie, 11.-13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 58 58. Zwick R, Müller M, Attems J, Burghuber OC. Ein 18-jähriges Mädchen mit Fieber, Husten und zystischen Läsionen in der Lunge. Fall des Jahres. Jahrestagung 2009 der Österreichischen Gesellschaft f. Pneumologie, 11.-13. Juni 2009; Salzburg. WiKliWo 2009, 121/17-18, A 65 59. Ruis M, Burghuber OC, Valipour A. Cardiac performance and neurohumoral activation in patients with stable chronic heart failure and sleep disordered breathing. Eur Respir J 2009, Suppl of the European Respiratory Society Annual Meeting 60. Breyer M-K 1,2,3, Rutten EPA 1, Spruit MA 1, Franssen FME 1, Wouters EFM 1,3. Effects of pulmonary rehabilitation on abnormal systemic levels of glucose, triglycerides and high density lipoprotein (HDL) and waist circumference in patients with COPD. Center of Expertise for Chronic Organic failure (Ciro), Horn/NL, Department of Respiratory and Critical Care Medicine and Ludwig Boltzmann Institute for COPD Vienna/A; Maastricht University Medical Centre + (MUMC+), Maastricht/NL Am J Respir Crit Care Med 2010, D 45, F 14 61. Urban M, Cekici L, Funk GC, Burghuber OC, Eickhoff P. Wolzt M, Valipour A. Insulin resistance may contribute to systemic vascular dysfunction in patients with COPD. Am J Respir Crit Care Med 2010, D 45, F 16 3.) Publikationen (Reviews, Editorials, Guidelines, Buchbeiträge)
1. Koller HK, Burghuber OC. Diffuse interstitielle Lungenkrankheiten mit besonderer Berücksichtigung des rheumatischen Formenkreises Z Rheumatologie 2003; 62: 122
2. Block LH, Ziesche R,. Kneussl M, Petkov V,Hesse C, Kähler C, Fruhwald F, Zach M, Burghuber OC, Fugger B. Konsensus-Empfehlung der Arbeitsgruppe pulmonalarterielle Hypertension der Österreichischen Gesellschaft für Lungenerkrankungen und Tuberkulose. WiKliWo 2003, 115/10: 351, IF 0.9
3. Valipour A, Burghuber OC. Non-invasive pressure support ventilation in patients with acute cardiogenic pulmonary edema: a critical appraisal. International Respiratory Care Clinics and Technology. Update in Respiratory Care Technology. Ed 2003-2006, Publisher: Editorial Mason/ GrupoAulamedica
4. Block LH, .Burghuber OC, Hartl S, Zwick H. Österreichische Gesellschaft für Lungenerkrankungen und Tuberkulose: Konsensus zum Management der chronisch obstruktiven Lungenkrankheiten (COPD) WiKliWo 2004, 116/7, 268, IF 0.9 5. Burghuber OC. Pulmonary embolism: Clinical features in Principles of Respiratory Medicine. Second edition ed. Albert RK, SG Spiro SG, Jett J Mosby International 2004
6. Burghuber OC. COPD - State of the Art Österreichische Ärztezeitung 2005; 9, 36 7. Burghuber OC. Editorial: Chronisch obstruktive Lungenerkrankung WiKliWo 2005, 155 (5/6), 77 8. Hartl S, Burghuber OC. Diagnostik der COPD. WiKliWo 2005, 155 (5/6), 90 9. Schenk, Stiebellehner L, Burghuber OC, Kneussl M, .Lang IM. Untersuchung des Lungekreislaufs mittels Rechtsherzkatheter Positionspapier des Kardiopulmonalen Arbeitskreises der Österreichischen Gesellschaft für Pneumologie und der Österreichischen Gesellschaft für Kardiologie WiKliWo 2005, 117/9, 651
10. Hartl S, Schmidt I. Atemphysiotherapie bei CVI unter Berücksichtigung der NIV – Optionen. Nicht-invasive Beatmung - Grundlagen und moderne Praxis / Prof. Dr. Bernd Schönhofer. 1. Auflage 2006 – Bremen: UNI-MED Science, 2006, P178 – 181 11. Funk GC. Stewart's acid-base approach. WiKliWo 2007, 119(13-14), 390-403 12. Valipour A, Ruis M, Burghuber OC Ist das obstruktive Schlafapnoesyndrom ein Risikofaktor für das metabolische Syndrom? J Hypertonie 2008; 12(2), 31-33 13. Valipour A. Gender aspects in sleep apnoea Int J Respir Care 2008, AUTUMN/WINTER 2008, 57 – 61 14. Hochmair MJ. Chemotherapy State of the Art. Jahreskongress der Österreichischen Gesellschaft für Pneumologie 2008, Wien. 15. Kohansal R, Soriano JB, Agusti A. Investigating the natural history of lung function: facts, pitfalls, and opportunities. Chest. 2009 May,135(5),1330-41 16. Valipour A, Burghuber OC. Schlafatemstörungen. WiKliWo, Education 2009 17. Burghuber OC, Valipour A. Knowing Chronic Obstructive Pulmonary Disease by Heart: Cumulating Evidence of Systemic Vascular Dysfunction. Am J Respir Crit Care Med 2009, 180, 487-488 18. Hochmair MJ, Schalleschak J. Gunk, GC, Valipour A, Breyer MK, Kohansal R, Prosch M, Kaufmann M, Mashaal S, Burghuber OC. Diagnostic yield of a two-hour sedimentation of pleural effusion in patients with suspected malignancy. ASCO Annual Meeting 2010 J Clin Oncol 28, 2010, Suppl. A 18111 19. Hochmair MJ. Idiopathische eosinophile Pneumonie. Jahreskongress der Österreichischen Gesellschaft für Pneumologie 2008, Wien. Universum Innere Med, Fallberichte 2, 2010
Osteoporosis Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older This measure is to be reported for all female patients aged 65 years and older — a minimum of once per reporting period. Measure description What if this process or outcome of care is not Percentage of female patients aged 65 years and older who have appropriate for your patient? a centra
Estrriol (E3) is one of the three physiologic estrogens found in the human body. The unique biochemical and biologic effects of estriol distinguish it among alternative FDA- approved chemical entities. Estriol, oestra-1, 3,5 (10)- triene- 3,16 α, 17 β-triol, is widely used as hormone replacement therapy in Europe and Japan since it obviates the need for progestin administration. There is